Pei Huo

USPTO Granted Patents = 14 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 45(Granted Patents)

Location History:

Milburn, NJ (US) (2020)
Millburn, NJ (US) (2009 - 2023)

Company Filing History:

12 out of 2,405

Merck Sharp + Dohme Corp.

1 out of 832,680

Other

patents

Years Active: 2009-2023

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11820805 - Conjugate based systems for controlled insulin delivery (2023-11-21),

2. 11058775 - Insulin dimer-incretin conjugates (2021-07-13),

3. 11041009 - Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes (2021-06-22),

4. 10800827 - Insulin receptor partial agonists (2020-10-13),

5. 10689430 - Insulin receptor partial agonists (2020-06-23),

6. 10183981 - Insulin receptor partial agonists (2019-01-22),

7. 10017556 - Insulin receptor partial agonists (2018-07-10),

8. 9889205 - Glucose-responsive insulin conjugates (2018-02-13),

9. 9427475 - Glucose-responsive insulin conjugates (2016-08-30),

10. 8623846 - Diazeniumdiolate cyclohexyl derivatives (2014-01-07),

11. 8354394 - Diuretics (2013-01-15),

12. 8119806 - Cicletanine derivatives (2012-02-21),

13. 7999107 - Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators (2011-08-16),

14. 7605171 - (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists (2009-10-20),

Title: Pei Huo: A Visionary in Innovation from Millburn, NJ

Introduction:

Pei Huo, a pioneering inventor hailing from Millburn, NJ, is renowned for his unwavering commitment to pushing the boundaries of innovation. With a total of 14 patents to his name, he stands at the forefront of groundbreaking developments in the field.

Latest Patents:

Pei Huo's latest patents demonstrate his ingenuity and forward-thinking approach to scientific advancements. One notable invention includes the development of Conjugate-Based Systems for Controlled Insulin Delivery. This patent introduces conjugates that enhance insulin delivery through a novel framework, showcasing Pei Huo's expertise in the healthcare realm. Additionally, his work on Insulin Dimer-Incretin Conjugates showcases his versatility in merging distinct scientific domains for the greater good of society.

Career Highlights:

Having worked at esteemed companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc., Pei Huo has honed his skills and expertise in the field of innovation. His contributions to these organizations have left a significant impact on the industry, solidifying his reputation as a trailblazer in the field of patents and inventions.

Collaborations:

Throughout his career, Pei Huo has collaborated with accomplished individuals such as Lin Yan and Songnian Lin. These partnerships have led to the development of cutting-edge technologies and inventions, further cementing his status as a visionary inventor.

Conclusion:

In conclusion, Pei Huo stands as a true visionary in the world of innovation, constantly striving to create a better future through his inventive spirit and dedication to progress. His groundbreaking patents, coupled with his successful career at renowned companies, underscore his significant contributions to the field of patents and inventions. Pei Huo's legacy as an inventor continues to inspire future generations to push the boundaries of what is possible in the realm of innovation.

This text is generated by artificial intelligence and may not be accurate.